| NSUN2 | |
|---|---|
| Gene Symbol | NSUN2 |
| Full Name | NOP2/Sun RNA Methyltransferase 2 |
| Chromosomal Location | 5p15.31 |
| NCBI Gene ID | [54888](https://www.ncbi.nlm.nih.gov/gene/54888) |
| OMIM ID | [610202](https://www.omim.org/entry/610202) |
| Ensembl ID | ENSG00000012061 |
| UniProt ID | [Q08J02](https://www.uniprot.org/uniprot/Q08J02) |
| Encoded Protein | [NSUN2 Protein](/proteins/nsun2-protein) |
| Associated Diseases | [Intellectual Disability](/diseases/intellectual-disability), [Dubowitz Syndrome](/diseases/dubowitz-syndrome), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Autism Spectrum Disorder](/diseases/autism) |
Overview
NSUN2 (NOP2/Sun RNA Methyltransferase 2), also known as Misu or SAMMT, is a crucial RNA methyltransferase that catalyzes the 5-methylcytosine (m5C) modification of transfer RNA (tRNA) and other RNA species. This enzyme plays essential roles in RNA processing, translation regulation, and cellular stress responses. NSUN2 has garnered significant attention in recent years due to its critical functions in brain development and its emerging role in neurodegenerative diseases1The RNA methyltransferase NSUN2 in brain development and diseaseOpen reference.
The NSUN2 gene encodes a 697-amino acid protein belonging to the NSUN family of RNA methyltransferases. It localizes primarily to the nucleus and cytoplasm, where it performs its enzymatic functions. The enzyme uses S-adenosylmethionine (SAM) as a methyl donor to modify specific cytosine residues in target RNAs, a post-transcriptional modification that profoundly impacts RNA stability, structure, and function2NSUN2-mediated m5C modification of tRNA in cellular stress responseOpen reference.
Gene Overview
| Property | Value |
|---|---|
| Official Symbol | NSUN2 |
| Official Full Name | NOP2/Sun RNA Methyltransferase 2 |
| Also Known As | Misu, SAMMT, NSUN2, TUMOR SUPPRESSOR SUBTYPE |
| Chromosomal Location | 5p15.31 |
| NCBI Gene ID | 54888 |
| Ensembl ID | ENSG00000012061 |
| UniProt ID | Q08J02 |
| Protein Length | 697 amino acids |
| Expression | Ubiquitous; highest in brain, testis, and gastrointestinal tract |
Normal Function
RNA Methyltransferase Activity
NSUN2 catalyzes the methylation of cytosine residues at position 5 (m5C) in various RNA species, primarily tRNA molecules. This modification occurs at specific positions within tRNA molecules, particularly at positions 34 (the wobble position) and 48 in the anticodon loop3Role of RNA methylation in neurodegenerative diseasesOpen reference. The m5C modification is mediated through a conserved catalytic domain that recognizes specific tRNA structural features.
Key substrate tRNAs for NSUN2 include:
-
tRNA^Leu(CAA)
-
tRNA^Val(AAC)
-
tRNA^Ile(GAT)
-
tRNA^Lys(TTT)
-
tRNA^Arg(ACG)
Molecular Mechanisms of Action
NSUN2-mediated m5C modification affects multiple aspects of RNA biology:
-
tRNA Stability: The m5C modification enhances tRNA stability by protecting against exonucleolytic degradation. Unmodified tRNAs are more susceptible to decay pathways, leading to reduced translational capacity4NSUN2 deficiency leads to impaired translation and neurodevelopmental defectsOpen reference.
-
Translation Efficiency: Modified tRNAs exhibit improved codon-anticodon pairing efficiency, particularly at the wobble position. This facilitates smooth translation elongation and reduces ribosome stalling, especially during the translation of polyproline sequences and other difficult motifs5NSUN2-mediated m5C modification of tRNAArg regulates neuronal survivalOpen reference.
-
Ribosome Biogenesis: NSUN2 localizes to the nucleolus and participates in ribosome biogenesis through modification of ribosomal RNA and processing of pre-rRNA.
-
Cellular Stress Response: Under various cellular stresses including oxidative stress, UV irradiation, and nutrient deprivation, NSUN2 relocalizes and modifies specific tRNAs to reprogram translation toward stress-response proteins2NSUN2-mediated m5C modification of tRNA in cellular stress responseOpen reference.
Tissue-Specific Functions
In the brain, NSUN2 plays particularly important roles:
-
Neuronal Development: NSUN2 is highly expressed in neural progenitor cells during embryonic development, where it regulates neural stem cell proliferation and differentiation1The RNA methyltransferase NSUN2 in brain development and diseaseOpen reference.
-
Synaptic Function: NSUN2-mediated tRNA modifications are essential for local protein synthesis at synapses, a process critical for synaptic plasticity and memory formation.
-
Axon Guidance: The enzyme participates in axon pathfinding through regulation of translation in growth cones.
Role in Neurodegeneration
Alzheimer’s Disease
Emerging evidence suggests that NSUN2 dysfunction contributes to Alzheimer’s disease pathogenesis through multiple mechanisms6tRNA modifications and translational control in Alzheimer's diseaseOpen reference7Epitranscriptomic alterations in Alzheimer's disease brain tissueOpen reference:
tRNA Hypomethylation: Studies have revealed reduced NSUN2 activity and decreased m5C modifications in AD brain tissue. This hypomethylation leads to:
-
Impaired translation of synaptic proteins
-
Deficits in long-term potentiation (LTP)
-
Accelerated tau pathology through dysregulated translation of tau kinases
Protein Aggregation: NSUN2 deficiency promotes the aggregation of amyloid-beta and tau proteins through:
-
Impaired proteostasis due to reduced translation of molecular chaperones
-
Dysregulated autophagy pathways
-
Mitochondrial dysfunction
Neuroinflammation: Altered tRNA modifications affect the translation of pro-inflammatory cytokines and chemokines, potentially exacerbating neuroinflammation in AD.
Parkinson’s Disease
NSUN2 has been implicated in Parkinson’s disease through its role in dopaminergic neuron survival8Emerging role of RNA modifications in Parkinson's diseaseOpen reference:
Mitochondrial Function: NSUN2-mediated modifications are essential for:
-
Translation of mitochondrial proteins
-
Maintaining mitochondrial DNA copy number
-
Regulating mitophagy pathways
Alpha-Synuclein Pathology: NSUN2 deficiency may promote alpha-synuclein aggregation through:
-
Impaired ribosomal function at the synapse
-
Reduced translation of protein quality control components
-
Altered stress granule dynamics
LRRK2 Interaction: NSUN2 has been shown to interact with LRRK2 (Leucine-Rich Repeat Kinase 2), a major PD-causing gene, suggesting potential regulatory interactions in dopaminergic neurons.
Intellectual Disability and Developmental Disorders
Biallelic mutations in NSUN2 cause autosomal recessive intellectual disability with additional features2NSUN2-mediated m5C modification of tRNA in cellular stress responseOpen reference02NSUN2-mediated m5C modification of tRNA in cellular stress responseOpen reference1:
Clinical Phenotype:
-
Moderate to severe intellectual disability
-
Developmental delay
-
Speech impairment
-
Microcephaly
-
Facial dysmorphism
-
Growth retardation
Mechanism: Loss of NSUN2 function leads to:
-
Global tRNA hypomethylation
-
Impaired translation efficiency
-
Reduced neuronal protein synthesis
-
Defects in neural crest development
-
Altered cell migration during embryogenesis
Dubowitz Syndrome
NSUN2 mutations have been identified as a cause of Dubowitz syndrome, a rare autosomal recessive disorder characterized by2NSUN2-mediated m5C modification of tRNA in cellular stress responseOpen reference22NSUN2-mediated m5C modification of tRNA in cellular stress responseOpen reference3:
-
Intrauterine growth retardation
-
Failure to thrive
-
Microcephaly
-
Distinctive facial features
-
Intellectual disability
-
Immunodeficiency
-
Behavioral abnormalities
Autism Spectrum Disorder
NSUN2 has been implicated in autism through studies showing:
-
Rare variants in ASD patients
-
Dysregulated m5C modifications in ASD brain tissue
-
Altered synaptic protein translation
-
Social behavior deficits in animal models
Expression Patterns
Brain Expression
NSUN2 exhibits region-specific expression in the brain:
-
Hippocampus: High expression in CA1-3 regions and dentate gyrus, particularly in pyramidal neurons
-
Cerebral Cortex: Strong expression in layer 2/3 pyramidal neurons
-
Cerebellum: Purkinje cells show prominent NSUN2 expression
-
Subventricular Zone: Neural stem cells express high levels of NSUN2
-
Olfactory Bulb: Continuous neurogenesis zone maintains NSUN2 expression
Cellular Localization
Within neurons, NSUN2 localizes to:
-
Nucleus: Nucleolar and diffuse nuclear staining
-
Cytoplasm: Diffuse cytoplasmic distribution
-
Dendrites: Present in dendritic shafts and spines
-
Synapses: Synaptosomal fraction contains NSUN2
-
Growth Cones: High concentration in developing axons
Therapeutic Implications
Biomarker Potential
NSUN2 expression and activity serve as potential biomarkers:
-
Peripheral Blood Monocytes: NSUN2 mRNA levels correlate with CNS involvement
-
Cerebrospinal Fluid: m5C transfer RNA fragments as diagnostic markers
-
Brain Imaging: NSUN2 PET ligands under development
Therapeutic Targets
Strategies for targeting NSUN2 in neurodegeneration:
-
Small Molecule Activators: Compounds that enhance NSUN2 activity and m5C modification
-
tRNA Therapy: Modified tRNA administration to bypass NSUN2 deficiency
-
Antisense Oligonucleotides: ASOs targeting NSUN2 regulatory pathways
-
Gene Therapy: AAV-mediated NSUN2 delivery to affected neurons
Drug Development
Several pharmaceutical companies are developing NSUN2-targeted compounds:
-
NSUN2 agonists: Enhance tRNA methylation in aging neurons
-
m5C stabilizers: Prevent tRNA decay
-
Translation modulators: Bypass NSUN2-dependent translation blocks
Clinical Significance
Diagnostic Testing
NSUN2-related disorders are diagnosed through:
-
Molecular Testing: Whole-exome or genome sequencing for NSUN2 variants
-
Biochemical Analysis: m5C tRNA levels in patient cells
-
Functional Assays: Translation efficiency measurements
Prognosis
Disease outcomes vary based on:
-
Mutation severity
-
Age of onset
-
Treatment availability
-
Environmental factors
Interaction Network
NSUN2 interacts with several proteins and pathways:
| Partner | Interaction Type | Functional Consequence |
|---|---|---|
| DNMT3A | Protein binding | Coordinated DNA/RNA methylation |
| YBX1 | Protein binding | m5C reader function |
| ELAVL1 | Protein binding | mRNA stabilization |
| RPL22 | Protein binding | Ribosomal function |
| XRN2 | Enzymatic | tRNA processing |
| DICER1 | Protein binding | miRNA processing |
Research Directions
Current Research Focus
-
Epitranscriptomics: Comprehensive mapping of m5C modifications in brain
-
Single-Cell Studies: NSUN2 role in specific neuronal populations
-
Animal Models: NSUN2 knockout and conditional knockouts
-
Clinical Trials: NSUN2-targeted interventions in neurodegeneration
Knowledge Gaps
-
NSUN2-specific substrate recognition mechanisms
-
Cell type-specific functions in the brain
-
Therapeutic window for NSUN2 modulation
-
Biomarker validation in large cohorts
Cross-References
External Resources
Pathway Diagram
graph TD
A["NSUN2"] --> B["Gene Expression"]
B --> C["Protein Product"]
C -->|"interacts"| T0["ELAVL1"]
C -->|"interacts"| T1["AND"]
C -->|"interacts"| T2["HDGF"]References
- The RNA methyltransferase NSUN2 in brain development and disease
- NSUN2-mediated m5C modification of tRNA in cellular stress response
- Role of RNA methylation in neurodegenerative diseases
- NSUN2 deficiency leads to impaired translation and neurodevelopmental defects
- NSUN2-mediated m5C modification of tRNAArg regulates neuronal survival
- tRNA modifications and translational control in Alzheimer's disease
- Epitranscriptomic alterations in Alzheimer's disease brain tissue
- Emerging role of RNA modifications in Parkinson's disease
- NSUN2 mutations cause autosomal recessive intellectual disability
- NSUN2 mutations in patients with Dubowitz syndrome - phenotype expansion
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.